Phase 3 Outcomes Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
The effect of lower salt exposure at haemodialysis on cardiac micro-injury, in home and self-care haemodialysis patients.
Cardiovascular outcomes
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12614000070639
Active
Phase 3
Investigating the utility of the customised fetal growth chart: a randomised controlled trial
Perinatal outcomes
Mater Medical Research Institue4,020 enrolled1 locationACTRN12612001215819
Recruiting
Phase 3
The effect of lower salt exposure on the cardiac structure and function of patients on home haemodialysis
Cardiovascular outcomes in dialysis patients
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12611000975998
Completed
Phase 2Phase 3
Hyperbaric Oxygen in Lower Limb Trauma
Acute open fractures of the tibia with associated severe soft tissue injuryOutcomesTrauma+2 more
Alfred Health120 enrolled11 locationsACTRN12607000559415
Completed
Phase 2Phase 3
The DRIP Trial
Phlebitis and other adverse outcomes of peripheral venous cannulation.
Joan Webster754 enrolled1 locationACTRN12605000147684